Lithium Chloride Lowers Brain Damage in Fetal Alcohol Syndrome

Lithium Chloride Reduces Sleep, Memory, and Learning Deficits Linked to Fetal Alcohol Syndrome in Mice

Summary: Researchers at NYU Langone report that a single dose of lithium chloride given to newborn mice shortly after high-dose alcohol exposure prevented later sleep disturbances, hyperactivity, and cognitive decline associated with fetal alcohol syndrome in this animal model.

Source: NYU Langone

Key findings

New experiments led by scientists at NYU School of Medicine show that a single post-exposure injection of lithium chloride can block several neurological consequences of early alcohol exposure in mice. When newborn mouse pups received lithium chloride 15 minutes after a binge-like alcohol exposure, the animals did not develop the pronounced hyperactivity, severe sleep fragmentation, or the approximate 25% decline in memory and cognitive test scores observed in untreated, alcohol-exposed mice as adults.

In the study, mice treated with lithium chloride after alcohol exposure displayed consolidated, undisrupted sleep durations comparable to mice that were never exposed to alcohol—about ten hours per day. By contrast, untreated mice exposed to alcohol woke repeatedly, up to dozens of times per hour. Because sleep quality is tightly linked to emotional regulation and cognitive performance, preserving normal sleep appears to be a major factor in protecting brain function following early alcohol damage.

Why mice are a useful model

The research team emphasizes that giving alcohol to mice shortly after birth provides a reasonable model for aspects of human fetal brain development. Many developmental milestones in mouse pups occur after birth but correspond to prenatal stages in humans, making early-postnatal exposure in mice a practical way to study mechanisms that may be relevant to human fetal alcohol spectrum disorders.

Possible mechanisms

Co-senior investigator Mariko Saito, PhD, notes that lithium chloride influences several cellular pathways that promote neuronal survival and repress cell-death signals. In particular, lithium is known to enhance factors such as brain-derived neurotrophic factor (BDNF), which supports neuron growth and resilience. The authors propose that lithium’s protective effect likely reflects a combination of blocking damaging biochemical cascades triggered by alcohol and boosting survival pathways.

Safety and future directions

The investigators caution that these findings are preclinical and do not justify using lithium chloride in pregnant women or newborns. Donald Wilson, PhD, a co-senior investigator, stresses that lithium chloride carries known toxicities to organs and would be too risky for routine use in pregnancy without extensive additional study. Instead, the researchers suggest that future therapies might mimic the protective biochemical actions of lithium—such as stimulating BDNF or related survival pathways—while minimizing side effects.

The team also plans to investigate whether lithium chloride or related compounds could reduce other types of neurological damage, including cell loss after stroke or traumatic brain injury, where similar cell-death pathways are involved.

A sleeping infant mouse as a model for developmental studies
The study brings scientists closer to understanding whether correcting sleep disturbances alone can reduce other developmental harms of fetal alcohol exposure. Photo credit: NeuroscienceNews.com (public domain).

Implications for fetal alcohol spectrum disorders

Sleep disruption is a consistent feature of fetal alcohol spectrum disorders in both animal models and people. The new results strengthen the idea that preserving healthy sleep architecture after early alcohol exposure may be a critical factor in preventing later cognitive and behavioral problems. While the exact relationship between sleep restoration and long-term cognitive outcomes requires further testing, this work identifies sleep as a promising therapeutic target.

About the study

The experiments were conducted at NYU Langone and the Nathan Kline Institute for Psychiatric Research. Co-senior investigators included Donald Wilson, PhD, and Mariko Saito, PhD. Co-lead investigators included Monica Lewin, MS, and M. Ilina. Additional study contributors were Judith Betz, Kurt Masiello, and Maria Hui.

Funding: This research was supported by the National Institute on Alcohol Abuse and Alcoholism, grant R01 AA023181.

Reporting: David March – NYU Langone. Publisher: NeuroscienceNews.com. The study was reported online in the journal Neuroscience and the original research is noted to appear in Nature Neuroscience.